.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, occu...
.Achilles Therapeutics has actually wrecked its technique. The English biotech is actually quiting w...
.Aligos Therapies is actually proclaiming a midstage gain in metabolic-dysfunction linked steatohepa...
.Basilea Pharmaceutica's work establishing new antifungals has actually acquired a substantial boost...
.Having actually scooped up the U.S. legal rights to Capricor Rehabs' late-stage Duchenne muscular d...
.After dismissing the decision date for Applied Rehabs' metabolic disorder medication govorestat, th...
.Novo Nordisk is proceeding its own push right into genetic medicines, accepting to compensate NanoV...
.Innovent Biologics has made the case that its own gate inhibitor-cytokine fusion protein possesses ...
.A period 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate ...
.Five months after Rakovina Rehabs pivoted toward artificial intelligence, the cancer-focused biotec...